{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T11:15:32Z","timestamp":1788606932961,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.prro.2021.01.004","type":"journal-article","created":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T22:40:54Z","timestamp":1611268854000},"page":"e415-e425","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["A Multi-Institutional Analysis of Radiation Dosimetric Predictors of Toxicity After Trimodality Therapy for Esophageal Cancer"],"prefix":"10.1016","volume":"11","author":[{"given":"Aurelie","family":"Garant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant","family":"Spears","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Routman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Whitaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongxing","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Harmsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Haddock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Hallemeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Merrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prro.2021.01.004_bib1","series-title":"Cancer Stat Facts: Esophageal Cancer","year":"2018"},{"key":"10.1016\/j.prro.2021.01.004_bib2","article-title":"Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancer","volume":"8","author":"Vellayappan","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.prro.2021.01.004_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cgh.2006.09.016","article-title":"Time trends of gastroesophageal reflux disease: A systematic review","volume":"5","author":"El\u2013Serag","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.prro.2021.01.004_bib4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/00365520600815654","article-title":"Rising incidence of clinically evident Barrett\u2019s oesophagus in The Netherlands: A nation-wide registry of pathology reports","volume":"42","author":"Post","year":"2007","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.prro.2021.01.004_bib5","first-page":"269","article-title":"Increasing trend of the incidence of esophageal squamous cell carcinoma, but not adenocarcinoma, in Taiwan","volume":"21","author":"Lu","year":"2010","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.prro.2021.01.004_bib6","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/sj.bjc.6605246","article-title":"Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977\u20132005","volume":"101","author":"Cook","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.prro.2021.01.004_bib7","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.ijrobp.2017.02.021","article-title":"A Multi-institutional Analysis of Trimodality Therapy for Esophageal Cancer in Elderly Patients","volume":"98","author":"Lester","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2021.01.004_bib8","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1002\/cncr.29857","article-title":"Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal cancer","volume":"122","author":"Lin","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.prro.2021.01.004_bib9","doi-asserted-by":"crossref","first-page":"855","DOI":"10.6004\/jnccn.2019.0033","article-title":"Esophageal and esophagogastric junction cancers, version 2.2019, NCCN clinical practice guidelines in oncology","volume":"17","author":"Ajani","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.prro.2021.01.004_bib10","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.radonc.2017.04.013","article-title":"Multi-institutional analysis of radiation modality use and postoperative outcomes of neoadjuvant chemoradiation for esophageal cancer","volume":"123","author":"Lin","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2021.01.004_bib11","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.radonc.2010.02.006","article-title":"Analysis of dose-volume histogram parameters for radiation pneumonitis after definitive concurrent chemoradiotherapy for esophageal cancer","volume":"95","author":"Asakura","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2021.01.004_bib12","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijrobp.2009.04.053","article-title":"Influence of irradiated lung volumes on perioperative morbidity and mortality in patients after neoadjuvant radiochemotherapy for esophageal cancer","volume":"77","author":"D\u00e4hn","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2021.01.004_bib13","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00130404-200211000-00009","article-title":"Effect of concurrent radiation therapy and chemotherapy on pulmonary function in patients with esophageal cancer: Dose-volume histogram analysis","volume":"8","author":"Gergel","year":"2002","journal-title":"Cancer J"},{"key":"10.1016\/j.prro.2021.01.004_bib14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.radonc.2014.11.037","article-title":"Is cardiac toxicity a relevant issue in the radiation treatment of esophageal cancer?","volume":"114","author":"Beukema","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2021.01.004_bib15","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ijrobp.2013.07.008","article-title":"Symptomatic pericardial effusion after chemoradiation therapy in esophageal cancer patients","volume":"87","author":"Fukada","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2021.01.004_bib16","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1200\/JCO.2003.03.055","article-title":"Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus","volume":"21","author":"Ishikura","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2021.01.004_bib17","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20140168","article-title":"Predictive factors for pericardial effusion identified by heart dose-volume histogram analysis in oesophageal cancer patients treated with chemoradiotherapy","volume":"88","author":"Hayashi","year":"2015","journal-title":"Br J Radiol"},{"key":"10.1016\/j.prro.2021.01.004_bib18","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.ijrobp.2006.06.002","article-title":"Dose\u2013volume modeling of the risk of postoperative pulmonary complications among esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery","volume":"66","author":"Tucker","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2021.01.004_bib19","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.ijrobp.2005.08.002","article-title":"Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery","volume":"64","author":"Wang","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2021.01.004_bib20","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/S0360-3016(03)01373-7","article-title":"Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: Correlation with pulmonary dose-volume histogram parameters","volume":"57","author":"Lee","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2021.01.004_bib21","doi-asserted-by":"crossref","first-page":"254","DOI":"10.7150\/jca.10796","article-title":"The prognostic value of irradiated lung volumes on the prediction of intra-\/post-operative mortality in patients after neoadjuvant radiochemotherapy for esophageal cancer. A retrospective multicenter study","volume":"6","author":"Kup","year":"2015","journal-title":"J Cancer"},{"key":"10.1016\/j.prro.2021.01.004_bib22","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.radonc.2017.04.013","article-title":"Multi-institutional analysis of radiation modality use and postoperative outcomes of neoadjuvant chemoradiation for esophageal cancer","volume":"123","author":"Lin","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2021.01.004_bib23","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.jtho.2020.06.014","article-title":"Incidence and onset of severe cardiac events after radiotherapy for esophageal cancer","volume":"15","author":"Wang","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.prro.2021.01.004_bib24","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ijrobp.2015.11.043","article-title":"Improving outcomes for esophageal cancer using proton beam therapy","volume":"95","author":"Chuong","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2021.01.004_bib25","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.radonc.2004.03.004","article-title":"Target dose conformity in 3-dimensional conformal radiotherapy and intensity modulated radiotherapy","volume":"71","author":"Wu","year":"2004","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2021.01.004_bib26","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1200\/JCO.19.02503","article-title":"Randomized phase IIB trial of proton beam therapy versus intensity-modulated radiation therapy for locally advanced esophageal cancer","volume":"38","author":"Lin","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2021.01.004_bib27","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S1470-2045(15)00040-6","article-title":"Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): Long-term results of a randomised controlled trial","volume":"16","author":"Shapiro","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2021.01.004_bib28","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/SLA.0000000000003031","article-title":"Robot-assisted minimally invasive thoracolaparoscopic esophagectomy versus open transthoracic esophagectomy for resectable esophageal cancer: A randomized controlled trial","volume":"269","author":"van der Sluis","year":"2019","journal-title":"Ann Surg"},{"key":"10.1016\/j.prro.2021.01.004_bib29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0167-8140(88)90296-4","article-title":"Adverse cardiac effects during induction chemotherapy treatment with cis-platin and 5-fluorouracil","volume":"13","author":"Eskilsson","year":"1988","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2021.01.004_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/2278-0513.125765","article-title":"Importance of pneumonitis induced by taxane-based chemotherapy and chemoradiotherapy for esophageal cancer","volume":"3","author":"Maraz","year":"2014","journal-title":"Clin Cancer Investig J"},{"key":"10.1016\/j.prro.2021.01.004_bib31","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.prro.2016.02.004","article-title":"Risk of radiation pneumonitis in patients receiving taxane-based trimodality therapy for locally advanced esophageal cancer","volume":"6","author":"Shaikh","year":"2016","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.prro.2021.01.004_bib32","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1245\/s10434-009-0401-0","article-title":"Association of clinical and dosimetric factors with postoperative pulmonary complications in esophageal cancer patients receiving intensity-modulated radiation\u00a0therapy and concurrent chemotherapy followed by thoracic esophagectomy","volume":"16","author":"Hsu","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.prro.2021.01.004_bib33","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.ijrobp.2011.10.053","article-title":"Comparison of heart and coronary artery doses associated with intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for distal esophageal cancer","volume":"83","author":"Kole","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2021.01.004_bib34","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/JTO.0b013e318195a625","article-title":"Induction chemoradiotherapy increases pleural and pericardial complications after esophagectomy for cancer","volume":"4","author":"Murthy","year":"2009","journal-title":"J Thorac Oncol"}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850021000096?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850021000096?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:23:12Z","timestamp":1761819792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879850021000096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S1879850021000096"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2021.01.004","relation":{},"ISSN":["1879-8500"],"issn-type":[{"value":"1879-8500","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Multi-Institutional Analysis of Radiation Dosimetric Predictors of Toxicity After Trimodality Therapy for Esophageal Cancer","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2021.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}